|
2024
|
Invention
|
Methods of treating autoimmune disease.
The invention provides immunomodulatory pharmaceutical c... |
|
|
Invention
|
Dyes for analysis of protein aggregation.
Provided are dyes and compositions which are useful in... |
|
2023
|
Invention
|
Sphingosine pathway modulating compounds for the treatment of cancers.
The invention provides me... |
|
|
Invention
|
Compositions for preparing regulatory t-cell compositions for the treatment of autoimmune disease... |
|
|
Invention
|
Blockchain-based biological sample storage. A computer-implemented system, method, and computer p... |
|
|
Invention
|
Sphingosine pathway modulating compounds for the treatment of coronavirus infection. The inventio... |
|
2022
|
G/S
|
Nucleic acid sequences and chemical reagents for in vitro laboratory use |
|
|
Invention
|
Method for detecting and quantifying dna methylation in a selected locus or region of dna. The in... |
|
2021
|
Invention
|
Use of organic cationic compounds to accelerate nucleic acid hybridization, synthesis, and amplif... |
|
|
G/S
|
Ophthalmic preparation for the treatment of ocular inflammation |
|
|
Invention
|
Immunomodulatory pharmaceutical compositions including a synthetic peptide and transforming growt... |
|
|
Invention
|
Pharmaceutical compositions and methods targeting wnt pathway proteins. Provided is a composition... |
|
|
G/S
|
Nucleic acid-type reagents for in vitro laboratory use. |
|
|
Invention
|
Fluorescence quencher polymer conjugates and uses thereof. The invention provides chemical conjug... |
|
|
Invention
|
Reduced background immunoassay plates. The invention provides reduced background substrates, such... |
|
|
Invention
|
Comprehensive and comparative flow cytometry-based methods for identifying the state of a biologi... |
|
|
Invention
|
Affinity tag nucleic acid and protein compositions and processes for using same.
The present inv... |
|
2020
|
Invention
|
Antibodies specific for sulfation sites of wnt pathway proteins. Provided is a protein comprising... |
|
|
Invention
|
Sphingosine pathway modulating compounds for the treatment of cancers. The invention provides met... |
|
|
Invention
|
Monoazo dyes with cyclic amine as fluorescence quenchers.
The present disclosure provides reacti... |
|
|
Invention
|
Immunomodulatory compositions and methods of use thereof.
Provided are immunomodulatory pharmace... |
|
|
Invention
|
Nucleic acid probes for in situ hybridization.
a The invention provides nucleic acid hybridizati... |
|
|
Invention
|
Digallic acid for reduction of inflammatory cytokine activity.
The present invention relates to ... |
|
|
Invention
|
Sulfonated sclerostin, antibodies, epitopes and methods for identification and use therefor. Prov... |
|
2019
|
Invention
|
Diagnosis and treatment of viral diseases. Herpesvirus saimiri infection. |
|
|
G/S
|
Providing booking services to patients for the provision of health care services at medical insti... |
|
|
Invention
|
Immunomodulatory pharmaceutical compositions. The invention provides immunomodulatory pharmaceuti... |
|
|
Invention
|
Method for promoting wound healing by administering a compound which binds ldl-receptor-related p... |
|
|
Invention
|
Methods and intermediates for synthesizing sk1-i. The invention provides methods for synthesizing... |
|
|
Invention
|
Methods for treating bone loss using sclerostin peptides. Provided is a composition comprising a ... |
|
|
Invention
|
In situ hybridization. The invention provides nucleic acid hybridization probes having improved d... |
|
2018
|
Invention
|
Affinity tag nucleic acid and protein compositions, and processes for using same. The present inv... |
|
|
Invention
|
Monoazo dyes with cyclic amine as fluorescence quenchers. The present disclosure provides reactiv... |
|
|
Invention
|
Nucleic acid probes for in situ hybridization. The invention provides nucleic acid hybridization ... |
|
|
Invention
|
Immunomodulatory compositions and methods of use thereof. Provided are immunomodulatory pharmaceu... |
|
2015
|
G/S
|
Assay for research purposes, namely, flow cytometry assay which detects mRNA expression in variou... |
|
2014
|
G/S
|
medical diagnostic reagents and assays for testing body fluids, namely, flow cytometry assay whic... |
|
2008
|
G/S
|
Assays and reagents for genomic, cellular and diagnostic applications for clinical or medical lab... |
|
2007
|
G/S
|
Chemical preparations for scientific purposes; chemicals for use in science; assays and reagents ... |
|
2006
|
G/S
|
Reagent kits for scientific use consisting primarily of primers, enzymes and buffers for use in t... |
|
|
G/S
|
House mark for a full line of biochemical reagents, particularly, antibodies, plasmids, enzymes, ... |
|
2002
|
G/S
|
fluorescent labeling systems, namely kits comprised of assays and reagents and dyes for use with ... |
|
1997
|
G/S
|
chemical reagents, namely, monoclonal antibodies for medical or scientific use and monoclonal ant... |
|
1996
|
G/S
|
reagents for scientific detection of hapten-labeled probes |
|
1995
|
G/S
|
house mark for full line of biochemical reagents, particularly, antibodies, plasmids, enzymes, en... |
|
1984
|
G/S
|
NUCLEIC ACID-TYPE REAGENTS FOR IN VITRO LABORATORY USE |
|
1982
|
G/S
|
NONRADIOACTIVE CHEMICALLY MODIFIED NUCLEOTIDES AND POLYNUCLEOTIDES FOR THE DETECTION OF SPECIFIC ... |
